Because serum EVs from TNBC patients promoted angiogenesis in an in vivo Matrigel plug assay in an ANXA2-dependent manner, ANXA2-bearing EVs may affect TNBC tumor progression [163]. Here, ANXA2 is linked to neoplasm.